Continence di culties a ect the lives of a substantial minority of the population. Women are far more likely than men to be a ected by urinary incontinence but the range of management options for them is limited. There has been considerable interest in developing an external urine collection system for women but without success to date. This paper describes the development and preliminary clinical testing of an active urine collection device (AUCD), which could provide a solution for su erers. The device uses stored vacuum, protected by a high bubble point lter, to remove urine as quickly as it is produced. This allows a small battery-operated pump to provide the required vacuum, enabling the device to be portable.
BACKGROUND
Urinary incontinence is a distressing condition that is very common throughout the population. Twice as many women as men experience urinary incontinence [1] and the incidence increases with age [2] . In the United Kingdom, continence aids and appliances alone cost the National Health Service (NHS ) around 70 million pounds a year [3] . The real costs of this condition are far higher because many people a ected by continence di culties will need carers to help them manage their condition. The cost of medical interventions to treat the complications associated with current continence management regimes, such as infections and pressure sores, is also considerable.
There are a wide range of surgical, pharmacological and physiotherapeutic treatments for incontinence [4] . While
The MS was received on 4 July 2002 and was accepted after revision for publication on 9 September 2002. these interventions can help many patients, a signi cant minority are left with severe, intractable incontinence. Management options for these patients are extremely limited; women in particular are often left with the choice of catheterization, with the near certainty of infections, or sitting in bulky pads. There have been a number of previous attempts to develop non-invasive urine collection devices to meet the tremendous need in this area but these have been largely unsuccessful to date [5] .
In 1997, Brunel Institute for Bioengineering was awarded an Action Research grant to develop a new method of managing severe urinary incontinence. This novel system was to be an active urine collection device (AUCD). The study was primarily aimed at transferring technologies developed for liquid handling in microgravity, to the problem of urinary incontinence. The aim of the project was to establish a solid technological foundation for developing a clinically applicable device. Following the development of a successful laboratory proof-of-principle prototype, a further Action Research grant was awarded to enable clinical prototypes to be developed and tested by patients.
AUCD DESIGN BRIEF

The patient/device interface (interface)
1. The interface should be non-invasive since invasive interventions such as catheterization carry a high risk of introducing infections. 2. There should be no airtight seal between the patient and the interface. In the past, many urine collection interfaces have attempted to create a seal between the interface and the user, either by the use of vacuum, adhesive or individually moulded interfaces. Individually moulded interfaces are expensive to produce and are user-speci c. Interfaces relying on vacuum or adhesion result in skin degradation. Furthermore, these three types of interface require skilled tting and the seal is easily compromised by patient movement. It was therefore decided that an interface that did not require a tight seal would be more practical and acceptable to most users. 3. The interface should only need to be changed in the morning and evening. This allows continence management to be incorporated into the patient's getting up and going to bed routine. 4. The interface should reliably collect urine without leaking. 5. The interface must be comfortable and safe. 6. The interface must be discreet and allow users to wear 'normal clothes'. 7. The interface must be easy to t and use, with no need for medical intervention.
The liquid handling system
1. The device must provide instant removal of urine at a owrate of up to 30 ml/s in order to remove liquid from the user as quickly as it is produced. Immediate liquid removal is required because, a few seconds delay in achieving the 30 ml/s owrate would lead to a considerable volume of urine accumulating at the collection area. 2. The system must be portable and have an independent power source. The size of the pump and power source that would be required to provide instant pumping at a owrate of up to 30 ml/s would compromise the systems' portability and practicality for the user. 3. There will be no airtight seal between the patient and the device, therefore ow is likely to be a mixture of liquid and air. Since air has a much lower viscosity than water, it will be preferentially drawn into any pumping system so the device must cope with mixed streams of air and liquid. 4. Collected urine should be stored away from the body in a container that can be emptied at the convenience of the user.
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For example, the device should be quiet and produce no odours. Figure 1 shows a schematic diagram of one version of the AUCD. A small battery-powered pump is used to evacuate a rigid storage container. When a predetermined vacuum is reached, a pressure transducer triggers the pump to stop evacuating the container. The pump is reactivated when the pressure within the container starts to rise again. A tube from the interface to the storage container is occluded by a solenoid valve in between voids. When a void occurs, an electronic sensor positioned in the interface senses that there is urine present and triggers the valve to open, allowing both air and liquid at the interface to be drawn into the tube. Air is prevented from entering the lined storage container by a high bubble point lter situated in the lid of the container. The surface tension of aqueous liquid in the pores of the lter provides a barrier against air while liquid can pass through easily. Once through the lter, the liquid is contained within a exible liner that ts inside the rigid container. In order to prevent an air lock forming in the tube there is a small bypass hole in the centre of the lter. The small amount of air that is allowed to enter the storage container is drawn away via the hydrophobic lters in the side of the liner.
BASIC OPERATION OF THE AUCD
HIGH BUBBLE POINT FILTER
Management of liquids is particularly di cult under the microgravity conditions found in space ight, because liquid and gas tend to ow as a mixture and gravityinduced ow is not possible. High bubble point materials have been successfully used in these conditions to separate mixed gas-liquid streams. The AUCD uses this same mechanism to separate air from the urine stream entering the storage container. The bubble point of a lter or fabric is the resistance of the wet material to the passage of air. The bubble point is created by the surface tension of the liquid within the pores of the material. The force with which the liquid in the pores resists air ingress is determined by the size and shape of the pores, the surface tension of the liquid and the contact angle between the liquid and the material. Poiseuille's law for capillary tubes gives the theoretical relationship between bubble point pressure and pore diameter when pores are perfect circles. The addition of a shape correction factor, K, makes the equation applicable to lters where pores are not perfectly circular.
The following equation can used to calculate the bubble By using a hydrophilic lter material, with a small pore size, air can be removed from a mixed ow even when a large pressure di erential is present.
Using a high bubble point lter in the AUCD
Air will enter the storage container in preference to liquid, unless the container is protected by the high bubble point lter. The graphs in Figs 2 and 3 show the pressure in the container and the rate at which the liquid is drawn into it; the graphs show what happens when a mixed stream of air and water is drawn into the device. In this laboratory demonstration, the liquid owrate was set at 250 ml/min to ensure a consistent amount of air entered the system each time. Figure 2 demonstrates the rapid loss of vacuum that occurs without the high bubble point lter where the pump cannot re-establish a vacuum below 80 mmHg. In this circumstance, the device would not be able to cope with rapid in ux of liquid at the interface because it is the pressure di erential between the storage container and the interface which draws the liquid into the device. Figure 3 shows the owrate and pressure within the Fig. 2 The e ect on pressure within the storage container of a mixed air and water ow when no high bubble point lter is in place. Pressure within the container rises dramatically at the start of the ow storage container with the bubble point lter in place. When the high bubble point lter is present, the pump has no di culty in maintaining the vacuum below 250 mmHg. Therefore, the device is ready to remove liquid at a high owrate at all times.
CLINICAL DEVICE DEVELOPMENT
For the device to be successful in a clinical situation it is vital that a owrate of 30 ml/s can be achieved. To cope with this owrate and the immediate start, the AUCD uses a stored vacuum that is released when urine is sensed to be present in the interface. To contain the vacuum, which is used as the suction source, it is Fig. 3 The e ect on pressure within the storage container of a mixed air and water ow when a high bubble point lter is present. Vacuum pressure within the container is maintained close to 300 mmHg by intermittent pumping necessary to use a valve. The valve cannot have any parts that are wetted by urine, because parts wetted by urine need to be changed at least weekly to prevent the build up of deposits and odours. As minimum power requirements are also important, it was decided to use a normally closed, latching solenoid pinch valve. This created some practical di culties because the standard for solenoid valves is normally open and not latching.
The tubing used between the interface and the storage area is also an important factor in ensuring that the critical owrate is maintained. The tubing needs to be wide bore to reduce resistance to the ow of liquid; however, above a critical bore size liquid will collect in any loops in the tube and not be drawn into the container. The tube also has to be exible to allow the tube to conform to a path which is comfortable to the user; it also has to be non-compressible so that it cannot become accidentally occluded. This means that the pinch valve must have a special insert of exible tube spliced into the main tubing to act on.
Every part of the tubing and lter system between the interface and the storage container will tend to slow the ow of liquid. Figure 4 shows how the weight of liquid collected by the AUCD changes with time. It can be seen from the slope of the curve that there is an initial peak ow of 40 ml/s that reduces to 30 ml/s after 5 s. The mean owrate of the system with all lters and pre-lters in place is 32 ml/s. This immediate high owrate, which is due to the instantaneous release of the vacuum stored in the container, is essential for the success of the AUCD system. Fig. 4 The AUCD liquid handling system drawing arti cial urine at maximum owrate compromises in design, materials and component parts, to produce a device which is su ciently robust and reliable for patient testing from o -the-shelf parts. Many of these modi cations have resulted in the prototype device being heavier and more cumbersome than the laboratory version.
Device modi cation
The clinical prototype has been produced in two sizes: a large-capacity device that only needs emptying once a day and a smaller device that needs emptying after each use. The larger device is ideal for wheelchair users who want to be free from the demands of managing their continence throughout the day. When in production, the smaller device will be able to t in a waist-worn bag. This single-use-capacity device could be used by people who are able to empty the device regularly.
Non-invasive interfaces are particularly di cult to design for female patients. A layered pad interface that collects urine, but does not absorb it, has been designed and prototyped. This non-absorbent pad has an integral sensor and tube. The vacuum created by the liquid handling system draws the urine from the pad as quickly as it is produced. When urine enters the pad, the temperature rises from the normal groin temperature of 34°C to 37°C. This temperature change is detected by the integral sensor, which triggers the solenoid valve to open, allowing the stored vacuum to reach the pad interface. Variations between individual thermal sensors meant that the detection of an absolute temperature change was unreliable as an indicator of urine ow. Therefore, it was necessary to use a programmable chip, that could be set to detect a step change in temperature, to control the device.
Device application
Initial clinical tests have used female urinal interfaces. Conventional female urinals can be di cult to use for a number of reasons. Firstly, it can be di cult to remove su cient clothing to use the urinal and so special clothing may be required. Many women nd the urinal dicult to insert because they have problems opening their thighs or sitting forward. In addition, when a woman is seated, the urinal is normally in a dip and therefore liquid leaving the urinal has to travel uphill. This means that without the AUCD liquid handling system, the user needs to remove the urinal when it is still full of urine. Many women nd this too di cult to achieve without spilling the contents. A slimline female urinal, speci cally for use with the AUCD liquid handling system, has been developed during the course of the project. This urinal is based on a 'Beambridge' female urinal and is known as the 'Dolphin'. The Dolphin has a small liquid capacity and is slim enough to slip down inside the loosened waistband of a skirt or trousers and elasticated underwear.
CLINICAL EVALUATION
Extensive clinical testing was carried out within the Continence Product Evaluation (CPE ) Network, Department of Medicine, University College London. Healthy volunteers were able to give considerable feedback and recommended some preliminary tests with subjects in the community. Testing by subjects showed that some further modi cations were needed before distributing the device to a larger number of users. Although the device was presented to users as a prototype, it was felt that when subjects test a device, comparatively minor technical issues like noise are really o -putting to them and it would have been di cult to test it further without addressing some of the key issues that were raised. Results of these preliminary tests on the liquid handling system and interfaces follow.
Liquid handling system
The clinical prototype was successfully tested by both healthy volunteers and patients. The process of prototype development involved input from the volunteers from the outset of the project. The volunteers identi ed a number of necessary functional design changes and recommended changes to the design to make the device easier to use.
It was originally anticipated that continent women with limited mobility would use the device with a manual vacuum release switch because they would be aware that they were about to urinate. However, the healthy volunteer testers found it extremely di cult to judge exactly when to release the vacuum. They also found the presence of two switches on the device confusing. It became apparent that an automatic vacuum release would be most appropriate for all users so the manual switch was abandoned. It was also discovered that when the device was tested with real urine rather than the water-based substitute used in the laboratory, the device would become progressively slower with each urination due to the presence of particulates in the urine. To counteract this e ect, two pre-lters were introduced into the system. The primary pre-lter was an in-line cartridge lter positioned in the tubing directly before the liquid handling system. The secondary glass-bre pre-lter had a pore size smaller than that of the high bubble point lter, and was placed on a support over the high bubble point lter. The inclusion of both lters enabled the device to work reliably, although the in-line cartridge lter used for this prototype needed to be changed daily. In the commercially produced device, it is anticipated that all of the lters could be combined into the lid of the container; this would then be disposable on a weekly basis.
It was evident from the feedback received from testers that the ideal liquid handling system would be comprised of two parts, with the storage container completely detachable for ease of emptying. This proved impossible at the prototype stage due to the expense of obtaining custom-made vacuum-tight connectors.
Patient/device interfaces
The 'Dolphin' slimline urinal was popular with users and easy to position but the sound of the liquid being drawn away was unacceptable. The urinal was designed to be used in private, so no problem with noise was expected but some users commented that they would be too embarrassed, by the sound of urine being drawn away very rapidly, to use the device in a public lavatory. The pad interface, which was successful in the laboratory tests, was not reliable when tested by volunteers. When the pad and tube were correctly positioned, urine was removed e ciently but it was very di cult to position the pad exactly. If the area for urine reception on the pad surface was badly placed or the tube moved from the end of the pad, serious leaks occurred. This interface is still under development and input from an ergonomics group will be critical in improving its performance.
CONCLUSIONS
This study has successfully demonstrated that a prototype AUCD liquid handling system can remove urine at clinically relevant owrates. Through the novel application of technology designed for liquid handling in microgravity, the AUCD has overcome problems associated with pumping mixed streams of liquid and air. As a result, it has been possible to develop a compact and portable liquid handling system. Initial tests have demonstrated that the AUCD will work in conjunction with either a female urinal or pad interface. While further development is required, tests with healthy volunteers and patients have shown that the AUCD could be a useful advance in continence management for women.
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